Stanley Hirsch - Net Worth and Insider Trading
Stanley Hirsch Net Worth
The estimated net worth of Stanley Hirsch is at least $19,459 dollars as of 2024-11-13. Stanley Hirsch is the Director of Foamix Pharmaceuticals Ltd and owns about 6,508 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $19,459. Details can be seen in Stanley Hirsch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stanley Hirsch has not made any transactions after 2018-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stanley Hirsch
Stanley Hirsch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stanley Hirsch owns 2 companies in total, including VYNE Therapeutics Inc (VYNE) , and Foamix Pharmaceuticals Ltd (FOMX) .
Click here to see the complete history of Stanley Hirsch’s form 4 insider trades.
Insider Ownership Summary of Stanley Hirsch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2020-03-09 | director |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | director |
Stanley Hirsch Latest Holdings Summary
Stanley Hirsch currently owns a total of 1 stock. Stanley Hirsch owns 6,508 shares of Foamix Pharmaceuticals Ltd (FOMX) as of May 13, 2018, with a value of $19,459.
Latest Holdings of Stanley Hirsch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd | 2018-05-13 | 6,508 | 2.99 | 19,459 |
Holding Weightings of Stanley Hirsch
Stanley Hirsch Form 4 Trading Tracker
According to the SEC Form 4 filings, Stanley Hirsch has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 6,164 shares on May 13, 2018, which brought Stanley Hirsch around $31,375.
Insider Trading History of Stanley Hirsch
- 1
Stanley Hirsch Trading Performance
Stanley Hirsch Ownership Network
Ownership Network List of Stanley Hirsch
Ownership Network Relation of Stanley Hirsch
Stanley Hirsch Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Stanley Hirsch is the director of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, Stanley Hirsch made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Stanley Hirsch Mailing Address
Above is the net worth, insider trading, and ownership report for Stanley Hirsch. You might contact Stanley Hirsch via mailing address: C/o Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot L3 76704.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
